Deciphering the molecular biology of inflammatory breast cancer through molecular characterization of patient samples and preclinical models

This publication has 112 references indexed in Scilit:

• ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-β1/SMAD3 signaling
  Clinical and Experimental Medicine, 2022
• The CD151‐midkine pathway regulates the immune microenvironment in inflammatory breast cancer
  The Journal of Pathology, 2020
• NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
  Molecular Oncology, 2019
• Prevalence of germline variants in inflammatory breast cancer
  Cancer, 2019
• Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem‐Like Cells
  Small, 2019
• Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database
  Journal of Cancer Research and Clinical Oncology, 2016
• miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness
  International Journal of Cancer, 2013
• Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
  Cancer, 2011
• Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro
  Journal of Cancer Research and Clinical Oncology, 2006
• Evidence of chromosome regions and gene involvement in inflammatory breast cancer
  International Journal of Cancer, 2002